Says “doesn’t know” what’s behind the FDA’s claims that the Covid vaccine killed 10 children, commenting that “to be honest, we haven’t seen any data.” Says takes safety “very seriously,” says has “rigorous monitoring” across the company, across the FDA, across over 90 countries, across the globe. Says safety monitoring systems “haven’t really given us anything new or anything undisclosed.” Says “going to have to weigh both sides of this.” Comments taken from the Piper Sandler 37th Annual Healthcare Conference. Shares of Moderna (MRNA) are down 0.4% to $24.07 in morning trading.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Vanguard S&P 500 ETF (VOO) Daily Update, 12/2/2025
- Vaccine committee considers changes to childhood schedule, NY Times reports
- Moderna put volume heavy and directionally bearish
- MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today
- Prasad email a headwind for vaccine manufacturers, says BofA
